REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $0 | – | 16 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 16 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 16 | -92.0% | 0.00% | – |
Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q1 2018 | $144,000 | -30.8% | 200 | 0.0% | 0.00% | – |
Q4 2017 | $208,000 | -16.8% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $250,000 | +26.9% | 200 | 0.0% | 0.00% | – |
Q2 2017 | $197,000 | -40.3% | 200 | 0.0% | 0.00% | – |
Q1 2017 | $330,000 | -26.7% | 200 | 0.0% | 0.00% | – |
Q4 2016 | $450,000 | -31.8% | 200 | 0.0% | 0.00% | – |
Q3 2016 | $660,000 | +14.2% | 200 | 0.0% | 0.00% | – |
Q2 2016 | $578,000 | -54.0% | 200 | 0.0% | 0.00% | – |
Q1 2016 | $1,256,000 | +62700.0% | 200 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |